145 related articles for article (PubMed ID: 33256657)
21. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
[TBL] [Abstract][Full Text] [Related]
22. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
23. Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors.
Giannis D; Cerullo M; Moris D; Shah KN; Herbert G; Zani S; Blazer DG; Allen PJ; Lidsky ME
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535552
[TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract][Full Text] [Related]
25. The surgical management of locally advanced well-differentiated thyroid carcinoma: changes over the years according to the AJCC 8th edition Cancer Staging Manual.
Metere A; Aceti V; Giacomelli L
Thyroid Res; 2019; 12():10. PubMed ID: 31673294
[TBL] [Abstract][Full Text] [Related]
26. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
27. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
28. Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Trybek T; Walczyk A; Gąsior-Perczak D; Pałyga I; Mikina E; Kowalik A; Hińcza K; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
Endocrinology; 2019 Oct; 160(10):2328-2338. PubMed ID: 31305897
[TBL] [Abstract][Full Text] [Related]
29. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
30. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
Cates JMM
J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
[No Abstract] [Full Text] [Related]
31. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
[TBL] [Abstract][Full Text] [Related]
33. Clinical Value of Lymph Node Ratio Integration with the 8
Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
[TBL] [Abstract][Full Text] [Related]
34. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study.
Sheng W; Dong M; Wang G; Shi X; Gao W; Wang K; Song H; Shi G; Tan X
BMC Cancer; 2019 Oct; 19(1):981. PubMed ID: 31640615
[TBL] [Abstract][Full Text] [Related]
35. The Clinicopathological Features of Papillary Thyroid Carcinoma Patients with Positive Hepatitis B Surface Antigen.
Zhong Z; Yuan J; Chen X; Chen Z; Du J; Chen Z; Kuang J; Cong S; Li J; Wu Z
Oncol Res Treat; 2020; 43(1-2):27-33. PubMed ID: 31722345
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma.
Póvoa AA; Teixeira E; Bella-Cueto MR; Melo M; Oliveira MJ; Sobrinho-Simões M; Maciel J; Soares P
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138175
[TBL] [Abstract][Full Text] [Related]
37. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
Ruiz ES; Karia PS; Besaw R; Schmults CD
JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
[TBL] [Abstract][Full Text] [Related]
38. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
[TBL] [Abstract][Full Text] [Related]
39. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
40. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
